Rare Disease & Gene Therapy Digest • September 28, 2026 Rare Disease & Gene Therapy Digest September 28, 2026 The FDA approved zilurgisertib (Atebrioz) on September 25, 2026… Pro Hub Membership Required You must be a Pro Hub member to access this content. Join Now Already a member? Log in here